FDA 483 - MMC HEALTHCARE LTD. - March 30, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
NMC HEALTHCARE LTD. in Chennai, India, was inspected by the FDA from March 25-30, 2024, as a drug manufacturer. The inspection revealed significant deficiencies across quality, production, laboratory, and facility systems, including critical data integrity issues, lack of proper process validations, inadequate laboratory controls, and basic facility shortcomings. These observations indicate a severe lack of adherence to cGMPs, posing potential risks to drug product quality and patient safety.
ID · 44176f28-da66-4aed-a15f-40c0264f051f